CA19-9 elevation in ovarian mature cystic teratoma: Discrimination from ovarian cancer – CA19-9 level in teratoma

BACKGROUND: We aimed to identify clinical characteristics of ovarian mature cystic teratoma (MCT) in association with CA19-9 elevation, and to determine if CA19-9 is a useful marker in discrimination of MCT from ovarian cancer (OC). MATERIAL/METHODS: Medical records of 322 women with pathologically-...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Hye-yon, Kim, Kidong, Jeon, Yong-Tark, Kim, Yong-Beom, No, Jae Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2013
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3628710/
https://www.ncbi.nlm.nih.gov/pubmed/23539074
http://dx.doi.org/10.12659/MSM.883865

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3628710/
https://www.ncbi.nlm.nih.gov/pubmed/23539074
http://dx.doi.org/10.12659/MSM.883865

Ejemplares similares